Profile data is unavailable for this security.
About the company
Bafna Pharmaceuticals Limited is an India-based company, which is engaged in manufacturing of pharmaceutical formulations. The Company exports its products to the Europe, the United Kingdom, Australia, Sri Lanka, Africa, and Commonwealth countries.
- Revenue in INR (TTM)1.47bn
- Net income in INR96.61m
- Incorporated1995
- Employees406.00
- LocationBafna Pharmaceuticals LtdBafna Towers, 299, Thambu Chetty streetCHENNAI 600001IndiaIND
- Phone+91 4 442677555
- Fax+91 4 442677599
- Websitehttp://www.bafnapharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quest Laboratories Ltd | 1.10bn | 136.79m | 2.11bn | 50.00 | 15.42 | 2.34 | 14.61 | 1.91 | 8.34 | 8.34 | 67.15 | 54.88 | 0.8914 | 3.33 | 3.60 | 22,028,980.00 | 11.07 | -- | 15.63 | -- | 14.94 | -- | 12.42 | -- | 2.04 | 6.81 | 0.2672 | -- | 25.92 | -- | 34.40 | -- | -- | -- |
| Brooks Laboratories Ltd | 888.46m | 216.03m | 2.23bn | 323.00 | 10.36 | -- | 9.64 | 2.51 | 7.32 | 7.32 | 30.45 | -- | -- | -- | -- | 2,750,638.00 | -- | -14.21 | -- | -23.39 | 38.75 | 25.99 | 24.31 | -25.22 | -- | -- | -- | -- | 3.86 | 3.45 | 49.13 | -- | -18.61 | -- |
| Vaidya Sane Ayurved Laboratories Ltd | 979.90m | 87.17m | 2.27bn | 636.00 | 27.94 | 3.35 | 16.29 | 2.32 | 7.73 | 7.73 | 85.76 | 64.41 | 1.27 | 4.62 | 15.21 | -- | 11.32 | 7.04 | 13.25 | 9.52 | 83.84 | 73.31 | 8.91 | 4.29 | 2.32 | 84.89 | 0.0092 | -- | -9.55 | 3.61 | 260.35 | -- | 17.02 | -- |
| Sat Kartar Life Ltd | -100.00bn | -100.00bn | 2.29bn | 922.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 21.07 | -- | 34.79 | -- | 93.36 | -- | 4.50 | -- | -- | -- | 5.39 | 27.37 | 56.31 | 55.66 | 117.33 | 39.27 | -- |
| Lyka Labs Ltd | 1.34bn | -6.54m | 2.46bn | 499.00 | -- | -- | 32.90 | 1.84 | -0.1801 | -0.1801 | 37.32 | -- | -- | -- | -- | 2,682,217.00 | -- | 2.35 | -- | 3.44 | 60.96 | 61.79 | -0.2546 | 3.29 | -- | -0.3263 | -- | -- | 24.55 | 17.63 | 421.84 | -- | 70.13 | -- |
| Nectar Lifesciences Ltd | 7.17bn | -1.26bn | 2.60bn | 1.79k | -- | -- | -- | 0.363 | -5.64 | -15.87 | 32.08 | -- | -- | -- | -- | 4,014,993.00 | -- | -1.57 | -- | -2.87 | -7.31 | 15.34 | -17.57 | -2.24 | -- | -3.77 | -- | -- | -0.838 | -6.73 | -2,375.90 | -- | -4.37 | -- |
| Bafna Pharmaceuticals Ltd | 1.47bn | 96.61m | 2.93bn | 406.00 | 30.28 | -- | 20.48 | 1.99 | 4.09 | 4.09 | 62.41 | -- | -- | -- | -- | 3,631,478.00 | -- | 5.99 | -- | 8.81 | 32.63 | 34.24 | 6.55 | 5.94 | -- | 3.15 | -- | -- | -4.31 | 28.01 | -43.49 | -- | 72.56 | -- |
| ZIM Laboratories Ltd | 3.78bn | 69.83m | 3.47bn | 577.00 | 49.43 | -- | 12.79 | 0.9187 | 1.44 | 1.44 | 78.03 | -- | -- | -- | -- | 6,548,695.00 | -- | 4.08 | -- | 6.64 | 55.93 | 48.54 | 1.85 | 4.24 | -- | 1.35 | -- | 0.00 | 3.16 | 6.42 | -29.46 | 29.84 | 17.10 | -- |
Data as of Feb 16 2026. Currency figures normalised to Bafna Pharmaceuticals Ltd's reporting currency: Indian Rupee INR
